LogicBio Therapeutics, a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect.
Net income (FY, 2018)
EBIT (FY, 2018)
Market capitalization (16-Oct-2019)
Closing stock price (16-Oct-2019)
|USD||Q2, 2017||Q2, 2018|
Depreciation and Amortization
Cash From Operating Activities
LogicBio Therapeutics has 275 Twitter Followers. The number of followers has increased 5% month over month and increased 11.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was LogicBio Therapeutics founded?
LogicBio Therapeutics was founded in 2014.
Who are LogicBio Therapeutics key executives?
LogicBio Therapeutics's key executives are Frederic Chereau.
How many employees does LogicBio Therapeutics have?
LogicBio Therapeutics has 23 employees.
Who are LogicBio Therapeutics competitors?
Competitors of LogicBio Therapeutics include Immunocore, Agenus and ARCA biopharma.
Where is LogicBio Therapeutics headquarters?
LogicBio Therapeutics headquarters is located at 610 Main St 3rd Floor, Cambridge.
Where are LogicBio Therapeutics offices?
LogicBio Therapeutics has an office in Cambridge.
How many offices does LogicBio Therapeutics have?
LogicBio Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies